Follow
Pratik Chandrani, Dr.
Pratik Chandrani, Dr.
Medical Oncology Molecular Lab & Computational Biology Centre, Tata Memorial Centre, Mumbai
Verified email at actrec.gov.in
Title
Cited by
Cited by
Year
Frequency of EGFR mutations in 907 lung adenocarcioma patients of Indian ethnicity
A Chougule, K Prabhash, V Noronha, A Joshi, A Thavamani, P Chandrani, ...
PloS one 8 (10), e76164, 2013
952013
NGS-based approach to determine the presence of HPV and their sites of integration in human cancer genome
P Chandrani, V Kulkarni, P Iyer, P Upadhyay, R Chaubal, P Das, ...
British journal of cancer 112 (12), 1958-1965, 2015
592015
Coexistence of KRAS mutation with mutant but not wild-type EGFR predicts response to tyrosine-kinase inhibitors in human lung cancer
A Choughule, R Sharma, V Trivedi, A Thavamani, V Noronha, A Joshi, ...
British journal of cancer 111 (11), 2203-2204, 2014
392014
Non-typhoidal Salmonella DNA traces in gallbladder cancer
P Iyer, SG Barreto, B Sahoo, P Chandrani, MR Ramadwar, ...
Infectious agents and cancer 11 (1), 1-4, 2016
382016
Notch pathway activation is essential for maintenance of stem-like cells in early tongue cancer
P Upadhyay, S Nair, E Kaur, J Aich, P Dani, V Sethunath, N Gardi, ...
Oncotarget 7 (31), 50437, 2016
362016
Drug-sensitiveFGFR3 mutations in lung adenocarcinoma
P Chandrani, K Prabhash, R Prasad, V Sethunath, M Ranjan, P Iyer, ...
Annals of oncology 28 (3), 597-603, 2017
312017
Genomic characterization of tobacco/nut chewing HPV-negative early stage tongue tumors identify MMP10 as a candidate to predict metastases
P Upadhyay, N Gardi, S Desai, P Chandrani, A Joshi, B Dharavath, ...
Oral oncology 73, 56-64, 2017
292017
ERBB2 and KRAS alterations mediate response to EGFR inhibitors in early stage gallbladder cancer
P Iyer, SV Shrikhande, M Ranjan, A Joshi, N Gardi, R Prasad, ...
International journal of cancer 144 (8), 2008-2019, 2019
282019
Up-regulation of the kinase gene SGK1 by progesterone activates the AP-1–NDRG1 axis in both PR-positive and-negative breast cancer cells
M Godbole, T Togar, K Patel, B Dharavath, N Yadav, S Janjuha, N Gardi, ...
Journal of Biological Chemistry 293 (50), 19263-19276, 2018
182018
Metabolic rewiring in drug resistant cells exhibit higher OXPHOS and fatty acids as preferred major source to cellular energetics
S Salunkhe, SV Mishra, A Ghorai, A Hole, P Chandrani, A Dutt, ...
Biochimica et Biophysica Acta (BBA)-Bioenergetics 1861 (12), 148300, 2020
152020
miR-129-2 mediates down-regulation of progesterone receptor in response to progesterone in breast cancer cells
M Godbole, P Chandrani, N Gardi, H Dhamne, K Patel, N Yadav, S Gupta, ...
Cancer biology & therapy 18 (10), 801-805, 2017
122017
TMC-SNPdb: an Indian germline variant database derived from whole exome sequences
P Upadhyay, N Gardi, S Desai, B Sahoo, A Singh, T Togar, P Iyer, ...
Database 2016, 2016
112016
Molecular tumor board: Case 1-Interplay of EGFR, MET and PD-L1 in non-small cell lung carcinoma
A Kapoor, V Noronha, A Chougule, VM Patil, N Menon, A Joshi, ...
Cancer Research, Statistics, and Treatment 2 (2), 228, 2019
92019
Integrated genomics approach to identify biologically relevant alterations in fewer samples
P Chandrani, P Upadhyay, P Iyer, M Tanna, M Shetty, GV Raghuram, ...
BMC genomics 16 (1), 1-13, 2015
92015
The efficacy and safety of first-line therapy for the epidermal growth factor receptor mutant non-small cell lung cancer in older versus younger patients: A pooled analysis of …
A Kapoor, V Noronha, VM Patil, A Joshi, N Menon, A Chougule, ...
Cancer Research, Statistics, and Treatment 3 (1), 44, 2020
82020
Molecular characterization of lung squamous cell carcinoma tumors reveals therapeutically relevant alterations
A Joshi, R Mishra, S Desai, P Chandrani, H Kore, R Sunder, S Hait, P Iyer, ...
Oncotarget 12 (6), 578, 2021
72021
Resistance mechanisms to epidermal growth factor receptor inhibitors in non-small cell lung cancer
SK Bondili, R Nandhana, V Noronha, A Joshi, V Patil, N Menon, ...
Cancer Research, Statistics, and Treatment 3 (4), 801, 2020
72020
Merkel cell polyomavirus in Merkel cell carcinoma: Integration sites and involvement of the KMT2D tumor suppressor gene
R Arora, JE Choi, PW Harms, P Chandrani
Viruses 12 (9), 966, 2020
72020
Molecular tumor board: Case 2–Evolution of resistance in anaplastic lymphoma kinase driven non-small-cell lung carcinoma
A Kapoor, V Noronha, O Shetty, A Chougule, P Chandrani, VM Patil, ...
Cancer Research, Statistics, and Treatment 3 (1), 89, 2020
62020
Landscape of toll-like receptors expression in tumor microenvironment of triple negative breast cancer (TNBC): Distinct roles of TLR4 and TLR8
A Roychowdhury, M Jondhale, E Saldanha, D Ghosh, CK Panda, ...
Gene 792, 145728, 2021
52021
The system can't perform the operation now. Try again later.
Articles 1–20